Disparities in end-of-life care and place of death in people with malignant brain tumors-A Swedish registry study.

IF 2.5 Q2 CLINICAL NEUROLOGY
Neuro-oncology practice Pub Date : 2024-11-11 eCollection Date: 2025-06-01 DOI:10.1093/nop/npae113
Anneli Ozanne, Joakim Öhlén, Stina Nyblom, Asgeir Store Jakola, Anja Smits, Cecilia Larsdotter
{"title":"Disparities in end-of-life care and place of death in people with malignant brain tumors-A Swedish registry study.","authors":"Anneli Ozanne, Joakim Öhlén, Stina Nyblom, Asgeir Store Jakola, Anja Smits, Cecilia Larsdotter","doi":"10.1093/nop/npae113","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Malignant brain tumors often lead to death. While improving future treatments is essential, end-of-life care must also be addressed. To ensure equitable palliative care, understanding the place of death is crucial, as disparities may lead to inequity of care. This study aims to identify the place of death in adults with malignant brain tumors in Sweden, and the potential associations with official palliative care status by the ICD-10 code Z51.5, sociodemographic factors, health service characteristics, and healthcare service utilization.</p><p><strong>Methods: </strong>A population-level registry study examined the place of death among adults who died of malignant brain tumors in Sweden from 2013 to 2019. Descriptive statistics, univariable, and multivariable binary logistic regression analyses were performed.</p><p><strong>Results: </strong>We identified 3,888 adults who died from malignant brain tumors. Of these, 64.4% did not receive an official palliative care status. Specialized palliative care was not utilized in 57.2% at the place of death and in 80% of nursing home deaths. In the last month of life, 53.5% of hospital deaths involved 1 transfer, while 41.8% had 2 or more transfers. The odds ratio (OR) of dying in hospital versus at home was higher, with 2 or more transfers (OR 0.63 [0.40, 0.99]). The OR of dying in a hospital versus at home showed significant regional differences.</p><p><strong>Conclusions: </strong>Despite the severity of their diagnosis, only a minority of patients utilized specialized palliative services at death, and this varied by the place of death. Significant regional disparities were found between hospital and home deaths, indicating unequal end-of-life palliative care in this patient group.</p>","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":"12 3","pages":"511-519"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12137219/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npae113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Malignant brain tumors often lead to death. While improving future treatments is essential, end-of-life care must also be addressed. To ensure equitable palliative care, understanding the place of death is crucial, as disparities may lead to inequity of care. This study aims to identify the place of death in adults with malignant brain tumors in Sweden, and the potential associations with official palliative care status by the ICD-10 code Z51.5, sociodemographic factors, health service characteristics, and healthcare service utilization.

Methods: A population-level registry study examined the place of death among adults who died of malignant brain tumors in Sweden from 2013 to 2019. Descriptive statistics, univariable, and multivariable binary logistic regression analyses were performed.

Results: We identified 3,888 adults who died from malignant brain tumors. Of these, 64.4% did not receive an official palliative care status. Specialized palliative care was not utilized in 57.2% at the place of death and in 80% of nursing home deaths. In the last month of life, 53.5% of hospital deaths involved 1 transfer, while 41.8% had 2 or more transfers. The odds ratio (OR) of dying in hospital versus at home was higher, with 2 or more transfers (OR 0.63 [0.40, 0.99]). The OR of dying in a hospital versus at home showed significant regional differences.

Conclusions: Despite the severity of their diagnosis, only a minority of patients utilized specialized palliative services at death, and this varied by the place of death. Significant regional disparities were found between hospital and home deaths, indicating unequal end-of-life palliative care in this patient group.

Abstract Image

Abstract Image

恶性脑肿瘤患者临终关怀和死亡地点的差异——一项瑞典登记研究。
背景:恶性脑肿瘤常导致死亡。虽然改善未来的治疗方法至关重要,但临终关怀也必须得到解决。为了确保公平的姑息治疗,了解死亡地点至关重要,因为差异可能导致护理的不公平。本研究旨在确定瑞典成年恶性脑肿瘤患者的死亡地点,以及ICD-10代码Z51.5与官方姑息治疗状态、社会人口统计学因素、卫生服务特征和卫生保健服务利用之间的潜在关联。方法:一项人口水平的登记研究调查了2013年至2019年瑞典死于恶性脑肿瘤的成年人的死亡地点。描述性统计、单变量和多变量二元逻辑回归分析。结果:我们确定了3888名死于恶性脑肿瘤的成年人。其中,64.4%的人没有接受官方的姑息治疗。57.2%的死亡地点和80%的养老院死亡没有使用专门的姑息治疗。在生命的最后一个月,53.5%的医院死亡涉及1次转院,而41.8%的医院死亡涉及2次或更多次转院。在医院死亡与在家死亡的比值比(OR)更高,有2次或更多次转院(OR 0.63[0.40, 0.99])。在医院和在家中死亡的OR显示出显著的地区差异。结论:尽管他们的诊断很严重,但只有少数患者在死亡时使用了专门的姑息治疗服务,这因死亡地点而异。在医院和家庭死亡之间发现了显著的区域差异,表明在该患者组中临终临终姑息治疗不平等。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuro-oncology practice
Neuro-oncology practice CLINICAL NEUROLOGY-
CiteScore
5.30
自引率
11.10%
发文量
92
期刊介绍: Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信